首页> 外文期刊>Chemical biology and drug design >Synthesis and In Vitro Antibacterial Activity of (2S)-N-(Substitutedphenyl)-1-[(2R)-2-[(Formylhydroxyamino)Methyl]-1-Oxohexyl]-2-Pyrrolidinecarboxamides as Potential Peptide Deformylase Inhibitors
【24h】

Synthesis and In Vitro Antibacterial Activity of (2S)-N-(Substitutedphenyl)-1-[(2R)-2-[(Formylhydroxyamino)Methyl]-1-Oxohexyl]-2-Pyrrolidinecarboxamides as Potential Peptide Deformylase Inhibitors

机译:(2S)-N-(取代的苯基)-1-[(2R)-2-[(甲酰基羟氨基)甲基] -1-氧己基] -2-吡咯烷甲酰胺的合成和体外抗菌活性作为潜在的肽脱甲酰基酶抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

Gram-positive organisms have re-emerged as the major hospital pathogens, which make the unmet medical needs for antibacterial therapy even worse. In searching for potent agents against Gram-positive pathogens, novel (2S)-N-(substitutedphenyl)-1-[(2R)-2-[(formylhydroxyamino)methyl]-1-oxo hexyl]-2-pyrrolidinecarboxamides, analogues of peptide deformylase inhibitor LBM-415 were designed, synthesized and evaluated for their antibacterial activities in vitro. Many of these compounds exhibited high potency against Gram-positive organisms compared with reference agent: LBM-415.
机译:革兰氏阳性生物已重新成为医院的主要病原体,这使得未得到满足的抗菌治疗的医疗需求更加严重。在寻找针对革兰氏阳性病原体的有效药物时,新型(2S)-N-(取代苯基)-1-[(2R)-2-[(甲酰基羟氨基)甲基] -1-氧代己基] -2-吡咯烷甲酰胺,设计,合成和评价了肽去甲酰基酶抑制剂LBM-415的体外抗菌活性。与参考试剂LBM-415相比,这些化合物中的许多对革兰氏阳性生物均显示出高效力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号